Literature DB >> 21194014

Development and evaluation of chitosan-coated liposomes for oral DNA vaccine: the improvement of Peyer's patch targeting using a polyplex-loaded liposomes.

Sunee Channarong1, Wanpen Chaicumpa, Nuttanan Sinchaipanid, Ampol Mitrevej.   

Abstract

The aim of this study was to develop chitosan-coated and polyplex-loaded liposomes (PLLs) containing DNA vaccine for Peyer's patch targeting. Plain liposomes carrying plasmid pRc/CMV-HBs were prepared by the reverse-phase evaporation method. Chitosan coating was carried out by incubation of the liposomal suspensions with chitosan solution. Main lipid components of liposomes were phosphatidylcholine/cholesterol. Sodium deoxycholate and dicetyl phosphate were used as negative charge inducers. The zeta potentials of plain liposomes were strongly affected by the pH of the medium. Coating with chitosan variably increased the surface charges of the liposomes. To increase the zeta potential and stability of the liposome, chitosan was also used as a DNA condensing agent to form a polyplex. The PLLs were coated with chitosan solution. In vivo study of PLLs was carried out in comparison with chitosan-coated liposomes using plasmid encoding green fluorescence protein as a reporter. A single dose of plasmid equal to 100 μg was intragastrically inoculated into BALB/c mice. The expression of green fluorescence protein (GFP) was detected after 24 h using a confocal laser scanning microscope. The signal of GFP was obtained from positively charged chitosan-coated liposomes but found only at the upper part of duodenum. With chitosan-coated PLL540, the signal of GFP was found throughout the intestine. Chitosan-coated PLL demonstrated a higher potential to deliver the DNA to the distal intestine than the chitosan-coated liposomes due to the increase in permanent positive surface charges and the decreased enzymatic degradation.
© 2010 American Association of Pharmaceutical Scientists

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21194014      PMCID: PMC3066342          DOI: 10.1208/s12249-010-9559-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  31 in total

1.  The effect of the degree of chitosan deacetylation on the efficiency of gene transfection.

Authors:  Tina Kiang; Jie Wen; Huay Wen Lim; Kam W Leong
Journal:  Biomaterials       Date:  2004-10       Impact factor: 12.479

2.  Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.

Authors:  Ulker Guliyeva; Filiz Oner; Sule Ozsoy; Rifki Haziroğlu
Journal:  Eur J Pharm Biopharm       Date:  2005-10-27       Impact factor: 5.571

Review 3.  New horizon of mucosal immunity and vaccines.

Authors:  Ichiro Takahashi; Tomonori Nochi; Yoshikazu Yuki; Hiroshi Kiyono
Journal:  Curr Opin Immunol       Date:  2009-06-01       Impact factor: 7.486

4.  Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity.

Authors:  Jamie F S Mann; Hannah E Scales; Eisin Shakir; James Alexander; Katharine C Carter; Alexander B Mullen; Valerie A Ferro
Journal:  Methods       Date:  2006-02       Impact factor: 3.608

5.  Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.

Authors:  Hiromitsu Yamamoto; Yoshio Kuno; Shohei Sugimoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  J Control Release       Date:  2005-02-02       Impact factor: 9.776

6.  Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.

Authors:  Sanyog Jain; Paramjit Singh; Vivek Mishra; S P Vyas
Journal:  Immunol Lett       Date:  2005-04-25       Impact factor: 3.685

7.  Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes.

Authors:  S Dokka; D Toledo; X Shi; V Castranova; Y Rojanasakul
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

8.  Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.

Authors:  Hirofumi Takeuchi; Yuji Matsui; Hikaru Sugihara; Hiromitsu Yamamoto; Yoshiaki Kawashima
Journal:  Int J Pharm       Date:  2005-10-13       Impact factor: 5.875

9.  Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

Authors:  M Conacher; J Alexander; J M Brewer
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

Review 10.  Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.

Authors:  S M van der Merwe; J C Verhoef; J H M Verheijden; A F Kotzé; H E Junginger
Journal:  Eur J Pharm Biopharm       Date:  2004-09       Impact factor: 5.571

View more
  12 in total

Review 1.  Engineering liposomal nanoparticles for targeted gene therapy.

Authors:  C Zylberberg; K Gaskill; S Pasley; S Matosevic
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

Review 2.  Micro- and nanoparticulates for DNA vaccine delivery.

Authors:  Eric Farris; Deborah M Brown; Amanda E Ramer-Tait; Angela K Pannier
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-04

3.  Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.

Authors:  Maria Manconi; Amparo Nácher; Virginia Merino; Matilde Merino-Sanjuan; Maria Letizia Manca; Carla Mura; Simona Mura; Anna Maria Fadda; Octavio Diez-Sales
Journal:  AAPS PharmSciTech       Date:  2013-03-08       Impact factor: 3.246

4.  Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia.

Authors:  Laurent Salade; Nathalie Wauthoz; Magali Deleu; Marjorie Vermeersch; Carine De Vriese; Karim Amighi; Jonathan Goole
Journal:  Int J Nanomedicine       Date:  2017-11-28

Review 5.  Barriers to Liposomal Gene Delivery: from Application Site to the Target.

Authors:  Mostafa Saffari; Hamid Reza Moghimi; Crispin R Dass
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

6.  Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity.

Authors:  Shabi Parvez; Ganesh Yadagiri; Archana Karole; Om Prakash Singh; Anurag Verma; Shyam Sundar; Shyam Lal Mudavath
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

7.  The dry powder formulation of mixed cross-linked dextran microspheres and tetanus toxoid-loaded trimethyl chitosan nanospheres as a potent adjuvant for nasal delivery system.

Authors:  Mona Kabiri; Haleh Bolourian; Solmaz Dehghan; Mohsen Tafaghodi
Journal:  Iran J Basic Med Sci       Date:  2021-01       Impact factor: 2.699

8.  Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity.

Authors:  Tarek A Ahmed
Journal:  BMC Pharmacol Toxicol       Date:  2020-02-21       Impact factor: 2.483

Review 9.  Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies.

Authors:  Michael Lim; Abu Zayed Md Badruddoza; Jannatul Firdous; Mohammad Azad; Adnan Mannan; Taslim Ahmed Al-Hilal; Chong-Su Cho; Mohammad Ariful Islam
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

Review 10.  Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases.

Authors:  Seyed Davoud Jazayeri; Hui Xuan Lim; Kamyar Shameli; Swee Keong Yeap; Chit Laa Poh
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.